• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.15% Nasdaq Up0.36%

    More On NVO


    Novo Nordisk A/S (NVO)

    -NYSE
    43.81 Down 0.59(1.33%) Dec 19, 4:06PM EST
    Add to Portfolio
    Analyst OpinionGet Analyst Opinion for:
    Recommendation Summary*
    Mean Recommendation (this week):2.0
    Mean Recommendation (last week):2.0
    Change:0.0

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Price Target Summary
    Mean Target:49.83
    Median Target:49.83
    High Target:56.66
    Low Target:43.00
    No. of Brokers:2

    Data provided by Thomson/First Call

    Upgrades & Downgrades History
    DateResearch FirmActionFromTo
    May 28, 2013Deutsche BankUpgradeSellHold
    Mar 31, 2010Deutsche BankInitiated Hold
    Mar 30, 2010Mehta PartnersDowngradeOutperformMarket Perform
    Feb 24, 2010Jefferies & CoUpgradeHoldBuy
    Jan 15, 2010Jefferies & CoDowngradeBuyHold
    Sep 11, 2009Jefferies & CoInitiated Buy
    Aug 7, 2009UBSDowngradeBuyNeutral
    Aug 7, 2009JP MorganDowngradeOverweightNeutral
    May 12, 2009Piper JaffrayInitiated Buy
    Apr 24, 2009CitigroupUpgradeHoldBuy

    More Upgrades & Downgrades for NVO

    Data provided by Briefing.com - Take a free trial
    Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

    Recommendation Trends
    Current MonthLast MonthTwo Months AgoThree Months Ago
    Strong Buy0111
    Buy0000
    Hold0111
    Underperform0000
    Sell0000

    Data provided by Thomson/First Call


    Currency in USD.